These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26955045)

  • 1. Modeling of Optimal Targeted Therapies Using Drug-Loaded Magnetic Nanoparticles for Liver Cancer.
    Mellal L; Folio D; Belharet K; Ferreira A
    IEEE Trans Nanobioscience; 2016 Apr; 15(3):265-74. PubMed ID: 26955045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer Model.
    Ludwig JM; Xing M; Gai Y; Sun L; Zeng D; Kim HS
    Mol Pharm; 2017 Aug; 14(8):2824-2830. PubMed ID: 28700244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancer.
    Jeon MJ; Gordon AC; Larson AC; Chung JW; Kim YI; Kim DH
    Biomaterials; 2016 May; 88():25-33. PubMed ID: 26938029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the delivery of cancer drugs that block angiogenesis.
    Cao Y; Langer R
    Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved drug targeting to liver tumors after intra-arterial delivery using superparamagnetic iron oxide and iodized oil: preclinical study in a rabbit model.
    Lee IJ; Ahn CH; Cha EJ; Chung IJ; Chung JW; Kim YI
    Invest Radiol; 2013 Dec; 48(12):826-33. PubMed ID: 23835597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized drug administration for cancer treatment using Model Reference Adaptive Control.
    Babaei N; Salamci MU
    J Theor Biol; 2015 Apr; 371():24-44. PubMed ID: 25665717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Modelling of Magnetic Nanoparticle Properties and In Vivo Responses.
    Winkler DA
    Curr Med Chem; 2017; 24(5):483-496. PubMed ID: 27758713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting DNA-mediated drug delivery in interior carcinoma using electromagnetically excited nanoparticles.
    Ghosh S; Das T; Chakraborty S; Das SK
    Comput Biol Med; 2011 Sep; 41(9):771-9. PubMed ID: 21752360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico studies of magnetic microparticle aggregations in fluid environments for MRI-guided drug delivery.
    Vartholomeos P; Mavroidis C
    IEEE Trans Biomed Eng; 2012 Nov; 59(11):3028-38. PubMed ID: 22907964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional bacterial magnetic nanoparticles for tumor targeting.
    Guo L; Huang J; Zheng LM
    Nanoscale; 2012 Feb; 4(3):879-84. PubMed ID: 22218728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Nonsmall Cell Lung Cancer.
    Munaweera I; Shi Y; Koneru B; Saez R; Aliev A; Di Pasqua AJ; Balkus KJ
    Mol Pharm; 2015 Oct; 12(10):3588-96. PubMed ID: 26325115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions.
    Mardinoglu A; Cregg PJ
    ScientificWorldJournal; 2015; 2015():618658. PubMed ID: 25815370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.
    Khodadust R; Unsoy G; Gunduz U
    Biomed Pharmacother; 2014 Oct; 68(8):979-87. PubMed ID: 25458787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment.
    Abedin F; Anwar MR; Asmatulu R; Yang SY
    J Biomater Appl; 2015 Jul; 30(1):38-49. PubMed ID: 25638169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.